Jenny Prange

Jenny Prange is a biotechnologist passionate about turning cutting-edge science into real-world therapies. As Head of Project Management at Wyss Translational Center Zurich and the Regenerative Medicine Technologies Platform at the University of Zurich, and Co-founder of MUVON Therapeutics, she brings extensive experience in cell therapy development and clinical manufacturing. From 2017 to 2025, Jenny established and led the production team responsible for manufacturing an autologous cell therapy for Phase I and II clinical trials. Today, she supports and guides projects at Wyss Zurich on their translational journey toward clinical production.